Caleb Scheckel to Molecular Targeted Therapy
This is a "connection" page, showing publications Caleb Scheckel has written about Molecular Targeted Therapy.
Connection Strength
0.040
-
Efficacy of BRAF-Inhibitor Therapy in BRAFV600E -Mutated Adult Langerhans Cell Histiocytosis. Oncologist. 2020 12; 25(12):1001-1004.
Score: 0.040
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.